Familial dysalbuminemic hyperthyroxinemia

From WikiMD's WELLNESSPEDIA

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Familial dysalbuminemic hyperthyroxinemia
Synonyms FDH
Pronounce N/A
Specialty N/A
Symptoms Elevated thyroxine (T4) levels, normal thyroid-stimulating hormone (TSH) levels
Complications Misdiagnosis of hyperthyroidism
Onset Congenital
Duration Lifelong
Types N/A
Causes Genetic mutation in the albumin gene
Risks Family history of FDH
Diagnosis Blood tests showing elevated T4, normal TSH, and genetic testing
Differential diagnosis Hyperthyroidism, euthyroid sick syndrome
Prevention N/A
Treatment None required, as it is a benign condition
Medication N/A
Prognosis N/A
Frequency Rare
Deaths N/A


Familial dysalbuminemic hyperthyroxinemia (FDH) is a rare genetic disorder characterized by elevated levels of total thyroxine (T4) in the blood due to an abnormal binding of thyroxine to serum albumin. This condition is often misdiagnosed as hyperthyroidism, but patients with FDH are typically euthyroid, meaning they have normal thyroid function.

Pathophysiology[edit]

FDH is caused by a mutation in the albumin gene, which leads to an altered albumin protein with increased affinity for thyroxine. This results in higher levels of total T4 in the bloodstream, while free T4 levels remain normal. The mutation is inherited in an autosomal dominant pattern, meaning only one copy of the mutated gene is sufficient to cause the disorder.

Diagnosis[edit]

Diagnosis of FDH involves blood tests that show elevated total T4 levels with normal free T4 and thyroid-stimulating hormone (TSH) levels. Genetic testing can confirm the presence of the albumin mutation. It is important to differentiate FDH from other causes of hyperthyroxinemia to avoid unnecessary treatment for hyperthyroidism.

Clinical Significance[edit]

FDH is clinically significant because it can lead to misdiagnosis and inappropriate treatment. Patients with FDH do not require treatment for hyperthyroidism, as their thyroid function is normal. Awareness of this condition is important for healthcare providers to prevent unnecessary interventions.

Management[edit]

No specific treatment is required for FDH, as it does not cause symptoms or complications. Management involves reassurance and education of the patient and their family about the benign nature of the condition.

Also see[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.